Trials / Unknown
UnknownNCT05458778
Detection of Urinary Human Chorionic Gonadotropin (hCG)
Detection of Urinary HCG During The Not Pregnancy and Pregnancy Cycles
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Quanovate Tech Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The Mira Pregnancy Test is an over-the-counter urine hCG test intended for early detection of pregnancy. The test is indicated for use four days before the expected period. Throughout this study, volunteers with non-medical backgrounds were recruited to test hCG with urine samples using the Mira Pregnancy Test during the not pregnancy cycle or pregnancy cycle. To perform the study, a total number of more than 200 volunteers will be recruited to participate in the study.
Detailed description
The studies include two parts, which are a lay user study and a urine samples test during the trying to conceive cycle. Part 1: Lay user study Part 2: Detection of hCG in Early Pregnancy Clinical Samples
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Daily test with urine by the product | Women perform the hCG test and share the test results |
Timeline
- Start date
- 2022-06-29
- Primary completion
- 2023-10-31
- Completion
- 2023-10-31
- First posted
- 2022-07-14
- Last updated
- 2023-05-01
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05458778. Inclusion in this directory is not an endorsement.